Health economics

HealthPartners Institute's Health Economics team has a history as the analysis group for the National Commission on Prevention Priorities. We have been recognized for our cost-effectiveness modeling experience, analysis of evidence-based preventive care policies, and economic analysis of clinical and health services interventions. Work began on the team’s economic models, which have been used in multiple ways to inform policy and medical decision-making locally and nationally, in 1999. Since then, the work has grown to include a family of models known collectively as HealthPartners Institute’s ModelHealth™ microsimulation models. The models address conditions such as obesity, tobacco use, colorectal and cervical cancers, sexually transmitted diseases and heart disease.


  • To help the U.S. Preventive Services Task Force update its aspirin recommendations, the team conducted microsimulation analyses using ModelHealth: Cardiovascular disease to identify those who are most likely to benefit from long-term aspirin use when the potential harms, such as serious bleeding in the stomach or brain, are considered. The result was much more precise guidance from the Task Force, tailored by age range and sex, on who should take daily aspirin to reduce the risk of heart disease or colorectal cancer. (Annals of Internal Medicine)
  • The team developed a website – – that provides planners, policy-makers and others with the tools to understand and compare the impact of evidence-based policies and programs in communities.
  • The team modeled the impact on childhood obesity of taxing sugar-sweetened beverages, banning child-directed fast-food advertising and implementing after-school physical activity programs.

To learn more about the models and their many uses, please see our ModelHealth™ page.